论文部分内容阅读
目的探讨硝苯地平控释片联合硫酸镁注射液治疗妊娠期高血压的临床疗效。方法选取2014年6月—2015年6月遂宁市船山区妇幼保健院收治的妊娠期高血压患者60例,随机分为对照组与观察组,各30例。对照组患者予以硫酸镁注射液治疗,观察组患者予以硝苯地平控释片联合硫酸镁注射液治疗。观察两组患者治疗前后血压情况及临床疗效。结果治疗前两组患者血压比较,差异无统计学意义(P>0.05),治疗后观察组患者血压低于对照组,差异有统计学意义(P<0.05);观察组患者总有效率高于对照组,差异有统计学意义(P<0.05)。结论硝苯地平控释片联合硫酸镁注射液治疗妊娠期高血压的临床疗效显著,可改善患者血压。
Objective To investigate the clinical efficacy of nifedipine controlled release tablets combined with magnesium sulfate injection in the treatment of gestational hypertension. Methods Sixty patients with gestational hypertension admitted to Chuanshan MCH Hospital of Suining City from June 2014 to June 2015 were randomly divided into control group and observation group, with 30 cases in each group. Patients in the control group were treated with magnesium sulfate injection. Patients in the observation group were treated with nifedipine controlled release tablets and magnesium sulfate injection. The blood pressure and clinical efficacy of two groups before and after treatment were observed. Results There was no significant difference in blood pressure between the two groups before treatment (P> 0.05). After treatment, the blood pressure of observation group was lower than that of control group (P <0.05). The total effective rate of observation group was higher than that of control group Control group, the difference was statistically significant (P <0.05). Conclusion Nifedipine controlled release tablets combined with magnesium sulfate injection in the treatment of gestational hypertension clinical efficacy significantly, can improve the patient’s blood pressure.